1. Home
  2. GRC vs EVO Comparison

GRC vs EVO Comparison

Compare GRC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$52.01

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.61

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
EVO
Founded
1933
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GRC
EVO
Price
$52.01
$3.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
68.9K
73.1K
Earning Date
02-06-2026
11-05-2025
Dividend Yield
1.41%
N/A
EPS Growth
31.51
N/A
EPS
1.91
N/A
Revenue
$678,522,000.00
$887,396,457.00
Revenue This Year
$4.94
N/A
Revenue Next Year
$4.02
$8.52
P/E Ratio
$28.14
N/A
Revenue Growth
3.19
N/A
52 Week Low
$30.87
$2.84
52 Week High
$54.26
$4.80

Technical Indicators

Market Signals
Indicator
GRC
EVO
Relative Strength Index (RSI) 57.45 58.06
Support Level $51.55 $3.39
Resistance Level $54.26 $3.63
Average True Range (ATR) 1.44 0.09
MACD 0.14 -0.00
Stochastic Oscillator 63.15 66.23

Price Performance

Historical Comparison
GRC
EVO

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: